Kyowa grew a modest 5% over the year-ago level. Its net profit halved
to Rs 68.6 crore constituting 11.3% of Lupin's consolidated profit.
"Pricing pressure in Japan has hit the company very hard, especially
last year. Since then, gross margins have dropped from 55% in FY18 to
31% in FY19," Lupin MD Nilesh Gupta said.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-looks-to-sell-japanese-arm-kyowa-for-600-million/articleshow/71845502.cms
No comments:
Post a Comment